Schonfeld Strategic Advisors LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 258,197 shares of RVPH stock, worth $98,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
258,197
Previous 1,058,100
75.6%
Holding current value
$98,114
Previous $1.83 Million
86.61%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RVPH
# of Institutions
56Shares Held
7.42MCall Options Held
938KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA1.8MShares$685,5540.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$583,0400.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$247,2740.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$193,9250.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$159,2720.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $7.77M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...